Regulation of T Cell and Mast Cell Function by DGKzeta

DGKzeta 对 T 细胞和肥大细胞功能的调节

基本信息

  • 批准号:
    7342494
  • 负责人:
  • 金额:
    $ 36.86万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-02-01 至 2011-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Much has been learned in recent years regarding the biochemical events most critical for signal transduction mediated by numerous cell surface receptors on immune cells. A key second messenger is diacylglycerol (DAG), which is formed when engaged ITAM-bearing receptors activate the phosphatidylinositol cascade. DAG, in turn, stimulates at least two critical signaling cascades; the Ras pathway and several protein kinase C family members. Thus, understanding the formation of DAG and its metabolism is key to understanding immune cell activation. One means by which DAG function is terminated is the conversion of DAG to phosphatidic acid by DAG kinases (DGKs). This proposal focuses on DGKzeta, one of two DGKs expressed at high levels in hematopoietic cells. Our preliminary data indicate that DGKzeta is an important in vivo negative regulator of T cell and mast cell function. The experiments described in this proposal will make use of cell lines and genetically altered mice to investigate how DGKzeta serves this key role. Three specific aims will be pursued. First, we propose a cell biologic and biochemical analysis of DGKzeta to determine its subcellular localization and features most critical for affecting signaling pathways. The second aim will investigate the impact of DGKzeta deficiency on in vivo T cell function and the third aim will examine similar questions in the mast cell compartment. Both aims 2 and 3 will extend the structure/function analysis to determine features of this enzyme most essential for responses to immunologic challenges. We anticipate that this work will shed additional light on the complex regulation of T cell and mast cell function and will hopefully suggest novel approaches to modulate activity of these cell types.
描述(由申请人提供):近年来,关于免疫细胞上许多细胞表面受体介导的信号转导最关键的生化事件,已经了解了很多。一个关键的第二信使是二酰基甘油(DAG),它是在接合的ITAM受体激活磷脂酰肌醇级联反应时形成的。DAG反过来刺激至少两个关键的信号级联; Ras途径和几个蛋白激酶C家族成员。因此,理解DAG的形成及其代谢是理解免疫细胞活化的关键。终止DAG功能的一种方法是通过DAG激酶(DGK)将DAG转化为磷脂酸。该提案集中于DGKzeta,这是造血细胞中高水平表达的两种DGKs之一。我们的初步数据表明DGKzeta是体内T细胞和肥大细胞功能的重要负调节因子。本提案中描述的实验将利用细胞系和基因改变的小鼠来研究DGKzeta如何发挥这一关键作用。将追求三个具体目标。首先,我们提出了DGKzeta的细胞生物学和生化分析,以确定其亚细胞定位和影响信号通路的最关键的功能。第二个目标将调查DGKzeta缺陷对体内T细胞功能的影响,第三个目标将研究肥大细胞区室中的类似问题。目标2和3将扩展结构/功能分析,以确定这种酶对免疫挑战反应最重要的特征。我们预计这项工作将进一步阐明T细胞和肥大细胞功能的复杂调控,并有望提出调节这些细胞类型活性的新方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GARY A. KORETZKY其他文献

GARY A. KORETZKY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GARY A. KORETZKY', 18)}}的其他基金

Regulation of T Cell and Mast Cell Function by DGKzeta
DGKzeta 对 T 细胞和肥大细胞功能的调节
  • 批准号:
    8093168
  • 财政年份:
    2010
  • 资助金额:
    $ 36.86万
  • 项目类别:
Regulation of Integrin Signaling by Adapter Proteins
接头蛋白对整合素信号传导的调节
  • 批准号:
    7323902
  • 财政年份:
    2007
  • 资助金额:
    $ 36.86万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    7313734
  • 财政年份:
    2007
  • 资助金额:
    $ 36.86万
  • 项目类别:
Lymphocyte Activation and Signaling
淋巴细胞激活和信号转导
  • 批准号:
    7058629
  • 财政年份:
    2006
  • 资助金额:
    $ 36.86万
  • 项目类别:
SIGNAL TRANSDUCTION IN THE IMMUNE SYSTEM-FASEB CONF.
免疫系统中的信号转导 - FASEB CONF。
  • 批准号:
    6940539
  • 财政年份:
    2005
  • 资助金额:
    $ 36.86万
  • 项目类别:
2005 Immunochemistry and Immunobiology Gordon Conference
2005年免疫化学和免疫生物学戈登会议
  • 批准号:
    6993506
  • 财政年份:
    2005
  • 资助金额:
    $ 36.86万
  • 项目类别:
Regulation of T Cell and Mast Cell Function by DGKzeta
DGKzeta 对 T 细胞和肥大细胞功能的调节
  • 批准号:
    7009321
  • 财政年份:
    2004
  • 资助金额:
    $ 36.86万
  • 项目类别:
Regulation of PMN activation by SLP-76, PRAM-1 and ADAP
SLP-76、PRAM-1 和 ADAP 对 PMN 激活的调节
  • 批准号:
    7225954
  • 财政年份:
    2004
  • 资助金额:
    $ 36.86万
  • 项目类别:
Regulation of T Cell and Mast Cell Function by DGKzeta
DGKzeta 对 T 细胞和肥大细胞功能的调节
  • 批准号:
    7172927
  • 财政年份:
    2004
  • 资助金额:
    $ 36.86万
  • 项目类别:
Regulation of T Cell and Mast Cell Function by DGKzeta
DGKzeta 对 T 细胞和肥大细胞功能的调节
  • 批准号:
    6845716
  • 财政年份:
    2004
  • 资助金额:
    $ 36.86万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 36.86万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.86万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 36.86万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.86万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 36.86万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 36.86万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.86万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 36.86万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 36.86万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.86万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了